All News MediPharm Labs Corp.

Equities

LABS

CA58504D1006

Market Closed - Toronto S.E. Other stock markets 03:59:59 2024-04-24 pm EDT			5-day change	1st Jan Change
0.08 ^CAD	+6.67%		0.00%	+23.08%

Mar. 27	MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	MT
Mar. 27	MediPharm Labs Narrows Q4 Loss, Revenue Grows	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MediPharm Labs Narrows Q4 Loss, Revenue Grows; Up 10.5%	Mar. 27	MT
MediPharm Labs Provides Conference Call Recording Details	Mar. 27	AQ
MediPharm Labs Narrows Q4 Loss, Revenue Grows	Mar. 27	MT
Transcript : MediPharm Labs Corp., Q4 2023 Earnings Call, Mar 27, 2024	Mar. 27
MediPharm Labs Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
MediPharm Labs Corp. Brief: Q4 Revenue $9.131 Million; Says Annual Revenue and Adjusted EBITDA Improve by 50%	Mar. 27	MT
MediPharm Labs Reports Fourth Quarter and Full Year Results	Mar. 27	AQ
MediPharm Labs Offers Update on German Cannabis Legalization; Up Nearly 6%	Mar. 25	MT
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023	Mar. 25	MT
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth	Mar. 25	MT
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization	Mar. 25	MT
MediPharm Labs Offers Update on German Cannabis Legalization	Mar. 25	MT
MediPharm Labs Corp. Brief: Says "Historic change is a significant positive step in removing the stigma related to medical cannabis"	Mar. 25	MT
MediPharm Labs Corp. Brief: Providing Update on German Cannabis Legalization	Mar. 25	MT
MediPharm Labs Provides Update on German Cannabis Legalization	Mar. 25	AQ
MediPharm Labs Provides Update on German Cannabis Legalization	Mar. 25	CI
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results	Mar. 22	AQ
MediPharm Labs Corp. Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	Feb. 07	MT
MediPharm Labs Corp. Brief: Says Achieved Pharmaceutical GMP Certification with Brazilian Health Authority	Feb. 07	MT
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority	Feb. 07	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News MediPharm Labs Corp.

Equities

LABS

CA58504D1006

All News

Filters